Please login to the form below

Not currently logged in
Email:
Password:

Shire adds Sara Mathew to board of directors

Comes as firm aims to become global biotechnology leader
Shire Sara Mathew

Shire has appointed Sara Mathew to its board of directors as a non-executive director.

Mathew who has previously served as chairman, president and CEO of Dun & Bradstreet will also be a member of the audit, compliance and risk committee of the Shire board.

During her 12-year tenure at Dun & Bradstreet she helped transform the company from being a data provider to an innovative digital enterprise that leverages big data, insights and analytics.

In 2013, Mathew was named the top value creator in the S&P 500 by Chief Executive magazine.

Susan Kilsby, chairman at Shire, said: “Sara is a highly-skilled global leader who has demonstrated success in driving strategy and transformation to deliver value for stakeholders.

“Sara also understands first-hand the power of disruptive technologies to substantially influence business in the future, an emerging dynamic in healthcare.

“I am confident that Sara's unique combination of skills and experience will further enrich the Shire Board of Directors as we advance towards becoming a global biotechnology leader.”

8th September 2015

From: Research, Sales

Share

Tags

Subscribe to our email news alerts

PMHub

Add my company
Oxford University Press

Oxford University Press publishes over 100 prestigious, highly cited, and authoritative medical journals, many in collaboration with some of the...

Latest intelligence

Healing the Healers
Because if we do not heal the healers, who is going to heal us?...
The (inevitable) digital transformation of Medical Affairs
It’s not a question of ‘if,’ it’s a question of ‘when.’...
Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...